{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T03:28:02Z","timestamp":1793762882088,"version":"4.6.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004881","name":"Instituto Mexicano del Seguro Social","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004881","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003141","name":"Secretar\u00eda de Ciencia, Humanidades, Tecnolog\u00eda e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["CVU 1142884"],"award-info":[{"award-number":["CVU 1142884"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Geriatric Nursing"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.gerinurse.2026.104291","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T07:23:11Z","timestamp":1787296991000},"page":"104291","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Characterization of polypharmacy and potential drug\u2013drug interactions in Mexican older adults with cognitive decline"],"prefix":"10.1016","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6232-7082","authenticated-orcid":false,"given":"Saliha Karina","family":"Hern\u00e1ndez-Ch\u00e1vez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1515-5684","authenticated-orcid":false,"given":"Angel Gabriel","family":"Garrido-Dzib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erandi","family":"Bravo-Armenta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6353-9060","authenticated-orcid":false,"given":"Roberto","family":"Lugo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3363-1477","authenticated-orcid":false,"given":"Azalia","family":"Avila-Nava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0373-4029","authenticated-orcid":false,"given":"Rodolfo","family":"Chim-Ake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4302-4753","authenticated-orcid":false,"given":"Ana Ligia","family":"Guti\u00e9rrez-Solis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.gerinurse.2026.104291_bib0001","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1001\/jamaneurol.2022.3543","article-title":"Estimating the prevalence of dementia and mild cognitive impairment in the US: the 2016 health and retirement study harmonized cognitive assessment protocol project","volume":"79","author":"Manly","year":"2022","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.gerinurse.2026.104291_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101703","article-title":"Prevalence of dementia in Latin America and Caribbean countries: systematic review and meta-analyses exploring age, sex, rurality, and education as possible determinants","volume":"81","author":"Ribeiro","year":"2022","journal-title":"Ageing Res Rev"},{"issue":"5","key":"10.1016\/j.gerinurse.2026.104291_bib0003","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1159\/000539560","article-title":"A systematic review and meta-analysis on the prevalence of mild cognitive impairment and dementia in Mexico","volume":"53","author":"Magall\u00f3n-Zertuche","year":"2024","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"9","key":"10.1016\/j.gerinurse.2026.104291_bib0004","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1111\/jgs.13612","article-title":"Multimorbidity and risk of mild cognitive impairment","volume":"63","author":"Vassilaki","year":"2015","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.gerinurse.2026.104291_bib0005","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.exger.2018.02.011","article-title":"Polypharmacy in people with dementia: associations with adverse health outcomes","volume":"106","author":"Mueller","year":"2018","journal-title":"Exp Gerontol"},{"issue":"10","key":"10.1016\/j.gerinurse.2026.104291_bib0006","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.3390\/medicina58101445","article-title":"Polypharmacy in older adults with Alzheimer\u2019s disease","volume":"58","author":"Esumi","year":"2022","journal-title":"Medicina"},{"issue":"1","key":"10.1016\/j.gerinurse.2026.104291_bib0007","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12877-017-0621-2","article-title":"What is polypharmacy? A systematic review of definitions","volume":"17","author":"Masnoon","year":"2017","journal-title":"BMC Geriatr"},{"issue":"4","key":"10.1016\/j.gerinurse.2026.104291_bib0008","first-page":"12","article-title":"Prevalencia y factores de riesgo para polifarmacia en adultos mayores del Valle del Mezquital","volume":"37","author":"Alvarado Orozco","year":"2006","journal-title":"Hidalgo. Rev Mex Cienc Farm"},{"issue":"Suppl 1","key":"10.1016\/j.gerinurse.2026.104291_bib0009","first-page":"29","article-title":"Polypharmacy prevalence and potentially inappropriate drug prescription in the elderly hospitalized for cardiovascular disease]","volume":"150","author":"Mart\u00ednez-Arroyo","year":"2014","journal-title":"Gac Med Mex"},{"key":"10.1016\/j.gerinurse.2026.104291_bib0010","article-title":"Patients with dementia: prevalence and type of drug\u2013drug interactions","volume":"15","author":"MC","year":"2024","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.gerinurse.2026.104291_bib0011","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s10433-024-00806-0","article-title":"Polypharmacy, drug-drug interactions, anticholinergic burden and cognitive outcomes: a snapshot from a community-dwelling sample of older men and women in northern Italy","volume":"21","author":"Perdixi","year":"2024","journal-title":"Eur J Ageing"},{"issue":"3","key":"10.1016\/j.gerinurse.2026.104291_bib0012","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1177\/003335490912400320","article-title":"OpenEpi: a web-based epidemiologic and statistical calculator for public health","volume":"124","author":"Sullivan","year":"2009","journal-title":"Public Health Reports\u00ae"},{"issue":"9","key":"10.1016\/j.gerinurse.2026.104291_bib0013","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1111\/jgs.17291","article-title":"Polypharmacy among older adults with dementia compared with those without dementia in the United States","volume":"69","author":"Growdon","year":"2021","journal-title":"J Am Geriatr Soc"},{"issue":"9","key":"10.1016\/j.gerinurse.2026.104291_bib0014","doi-asserted-by":"crossref","DOI":"10.1002\/fsn3.70859","article-title":"Identification of metabolite biomarkers associated with dietary patterns in individuals with mild cognitive impairment and dementia from Yucatan","volume":"13","author":"Garrido-Dzib","year":"2025","journal-title":"Food Sci Nutr"},{"key":"10.1016\/j.gerinurse.2026.104291_bib0015","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2024.1369766","article-title":"Meta-analysis of Montreal cognitive assessment diagnostic accuracy in amnestic mild cognitive impairment","volume":"15","author":"Malek-Ahmadi","year":"2024","journal-title":"Front Psychol"},{"issue":"9","key":"10.1016\/j.gerinurse.2026.104291_bib0016","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Lucy Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.gerinurse.2026.104291_bib0017","article-title":"World health organization technical report","author":"Mair","year":"2019","journal-title":"Medication Safety in Polypharmacy"},{"issue":"3","key":"10.1016\/j.gerinurse.2026.104291_bib0019","article-title":"Assessing consistency of drug-drug interaction-related information across various drug information resources","volume":"13","author":"Shariff","year":"2021","journal-title":"Cureus"},{"issue":"2","key":"10.1016\/j.gerinurse.2026.104291_bib0020","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s11192-009-0146-3","article-title":"Software survey: vOSviewer, a computer program for bibliometric mapping","volume":"84","author":"Van Eck","year":"2010","journal-title":"Scientometrics"},{"issue":"2","key":"10.1016\/j.gerinurse.2026.104291_bib0021","first-page":"154","article-title":"Descubrimiento de interacciones farmacol\u00f3gicas en MEDLINE con el uso de medidas de centralidad","volume":"27","author":"G\u00e1lvez","year":"2016","journal-title":"Rev Cuba Inf En Cienc Salud"},{"key":"10.1016\/j.gerinurse.2026.104291_bib0022","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1221069","article-title":"Global prevalence of polypharmacy and potentially inappropriate medication in older patients with dementia: a systematic review and meta-analysis","volume":"14","author":"Zhao","year":"2023","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.gerinurse.2026.104291_bib0023","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13195-026-01988-8","article-title":"Polypharmacy in people with dementia: a nationwide Danish study","volume":"18","author":"Pourhadi","year":"2026","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.gerinurse.2026.104291_bib0024","doi-asserted-by":"crossref","unstructured":"G\u00f3mez-Dant\u00e9s O, Dreser A, Wirtz VJ, Reich MR. Challenges of guaranteeing access to medicines in Mexico: lessons from recent changes in pharmaceuticals procurement. Health syst reform. 2022 Jan 1;8(1):2084221. doi:10.1080\/23288604.2022.2084221","DOI":"10.1080\/23288604.2022.2084221"},{"key":"10.1016\/j.gerinurse.2026.104291_bib0025","doi-asserted-by":"crossref","DOI":"10.1590\/1980-549720200077","article-title":"Polypharmacy, socioeconomic indicators and number of diseases: results from ELSA-Brasil","volume":"23","author":"Silva","year":"2020","journal-title":"Rev Bras Epidemiol"},{"key":"10.1016\/j.gerinurse.2026.104291_bib0026","doi-asserted-by":"crossref","unstructured":"Vargas L\u00f3pez LC, Ch\u00e1vez Gallegos D, Blanco Borjas DM, Wirtz VJ. Medicines policy, access and use in Mexico: a systematic literature review 2000\u20132022. Drugs context. 2024 Feb 12;13:1\u201317. doi:10.7573\/dic.2023-7-3","DOI":"10.7573\/dic.2023-7-3"},{"key":"10.1016\/j.gerinurse.2026.104291_bib0027","doi-asserted-by":"crossref","unstructured":"Agren D. Lack of medicines in Mexico. The Lancet. 2021 Jul;398(10297):289\u2013290. doi:10.1016\/S0140-6736(21)01656-1","DOI":"10.1016\/S0140-6736(21)01656-1"},{"issue":"Suppl 2","key":"10.1016\/j.gerinurse.2026.104291_bib0028","first-page":"S112","article-title":"Factor associated with medicines utilization and expenditure in Mexico]","volume":"55","author":"Wirtz","year":"2013","journal-title":"Salud Publica Mex"},{"issue":"2","key":"10.1016\/j.gerinurse.2026.104291_bib0029","doi-asserted-by":"crossref","first-page":"63","DOI":"10.19136\/hs.a15n2.1105","article-title":"Access to medication in Mexico: financing and equity","volume":"15","author":"Salazar","year":"2016","journal-title":"Horiz Sanit"},{"key":"10.1016\/j.gerinurse.2026.104291_bib0030","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.13.04134","article-title":"Equity in out-of-pocket health expenditure: evidence from a health insurance program reform in Mexico","volume":"13","author":"Garcia-Diaz","year":"2023","journal-title":"J Glob Health"},{"issue":"1","key":"10.1016\/j.gerinurse.2026.104291_bib0031","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1146\/annurev-publhealth-031816-044628","article-title":"The relationship between education and health: reducing disparities through a contextual approach","volume":"39","author":"Zajacova","year":"2018","journal-title":"Annu Rev Public Health"},{"issue":"1","key":"10.1016\/j.gerinurse.2026.104291_bib0032","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1532-5415.2008.02040.x","article-title":"The influence of educational level on polypharmacy and inappropriate drug use: a register-based study of more than 600,000 older people","volume":"57","author":"Haider","year":"2009","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.gerinurse.2026.104291_bib0033","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.2147\/NDT.S424694","article-title":"The relationship between level of education, cognitive function and medication adherence in patients with schizophrenia","volume":"Volume 19","author":"Zhu","year":"2023","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.gerinurse.2026.104291_bib0034","article-title":"Polypharmacy, chronic kidney disease, and mortality among older adults: a prospective study of national health and nutrition examination survey, 1999\u20132018","volume":"11","author":"Wang","year":"2023","journal-title":"Front Public Health"},{"issue":"2","key":"10.1016\/j.gerinurse.2026.104291_bib0035","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jamda.2019.07.007","article-title":"Polypharmacy and kidney function in community-dwelling adults age 60 years and older: a prospective observational study","volume":"21","author":"Ernst","year":"2020","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.gerinurse.2026.104291_bib0036","doi-asserted-by":"crossref","unstructured":"Kang H, Hong SH. Risk of kidney dysfunction from polypharmacy among older patients: a nested case-control study of the South Korean senior cohort. sci rep. 2019 Jul 18;9(1):10440. doi:10.1038\/s41598-019-46849-7","DOI":"10.1038\/s41598-019-46849-7"},{"issue":"12","key":"10.1016\/j.gerinurse.2026.104291_bib0037","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.2215\/CJN.03940321","article-title":"Association of polypharmacy with Kidney disease progression in adults with CKD","volume":"16","author":"Kimura","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.gerinurse.2026.104291_bib0038","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12882-024-03606-x","article-title":"Association between polypharmacy and chronic kidney disease among community-dwelling older people: a longitudinal study in southern China","volume":"25","author":"Zhang","year":"2024","journal-title":"BMC Nephrol"},{"issue":"1","key":"10.1016\/j.gerinurse.2026.104291_bib0039","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12916-014-0192-4","article-title":"Comorbidity and dementia: a scoping review of the literature","volume":"12","author":"Bunn","year":"2014","journal-title":"BMC Med"},{"issue":"Supplement_1","key":"10.1016\/j.gerinurse.2026.104291_bib0040","doi-asserted-by":"crossref","first-page":"S181","DOI":"10.2337\/dc25-S009","article-title":"Pharmacologic approaches to glycemic treatment: standards of care in diabetes\u20142025","volume":"48","author":"Committee","year":"2025","journal-title":"Diabetes Care"},{"issue":"02","key":"10.1016\/j.gerinurse.2026.104291_bib0041","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4103\/2231-0770.154194","article-title":"Assessment of drug-drug interactions in hypertensive patients at a superspeciality hospital","volume":"05","author":"Sivva","year":"2015","journal-title":"Avicenna J Med"},{"key":"10.1016\/j.gerinurse.2026.104291_bib0042","doi-asserted-by":"crossref","unstructured":"Salinas-Rodr\u00edguez A, Manrique-Espinoza B, Rivera-Almaraz A, \u00c1vila-Funes JA. Polypharmacy is associated with multiple health-related outcomes in Mexican community-dwelling older adults. Salud P\u00fablica M\u00e9xico. 2020 May 8;62(3, may-jun):246. doi:10.21149\/10903","DOI":"10.21149\/10903"},{"key":"10.1016\/j.gerinurse.2026.104291_bib0043","author":"Tao"},{"issue":"3","key":"10.1016\/j.gerinurse.2026.104291_bib0044","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S1262-3636(07)70273-2","article-title":"Differential effects of peroxisome proliferator-activated receptor ligands and sulfonylurea plus statin treatment on plasma concentrations of adipokines in type 2 diabetes with dyslipidemia","volume":"32","author":"Yin","year":"2006","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.gerinurse.2026.104291_bib0045","doi-asserted-by":"crossref","first-page":"921","DOI":"10.2147\/TCRM.S214938","article-title":"The clinical significance of statins-macrolides interaction: comprehensive review of in vivo studies, case reports, and population studies","volume":"Volume 15","author":"Abu Mellal","year":"2019","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.gerinurse.2026.104291_bib0046","doi-asserted-by":"crossref","unstructured":"Chen Y, Chen L, Zhang H, Huang S, Xiong Y, Xia C. Interaction of sulfonylureas with liver uptake transporters OATP1B1 and OATP1B3. basic clin pharmacol toxicol. 2018 Aug;123(2):147\u2013154. doi:10.1111\/bcpt.12992","DOI":"10.1111\/bcpt.12992"},{"issue":"9","key":"10.1016\/j.gerinurse.2026.104291_bib0047","article-title":"Interventions to improve the appropriate use of polypharmacy for older people - Rankin, A - 2018","volume":"2018","author":"Rankin","year":"2018","journal-title":"Cochrane Library"},{"issue":"sup1","key":"10.1016\/j.gerinurse.2026.104291_bib0048","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1080\/21548331.2019.1706995","article-title":"Polypharmacy in older adults: the role of the multidisciplinary team","volume":"48","author":"Baruth","year":"2020","journal-title":"Hosp Pract"}],"container-title":["Geriatric Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197457226004969?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197457226004969?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:32:05Z","timestamp":1791419525000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197457226004969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":47,"alternative-id":["S0197457226004969"],"URL":"https:\/\/doi.org\/10.1016\/j.gerinurse.2026.104291","relation":{},"ISSN":["0197-4572"],"issn-type":[{"value":"0197-4572","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of polypharmacy and potential drug\u2013drug interactions in Mexican older adults with cognitive decline","name":"articletitle","label":"Article Title"},{"value":"Geriatric Nursing","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gerinurse.2026.104291","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104291"}}